| 24 May 2013 |
Transaction in Own Shares |
| 23 May 2013 |
Block Listing Six Monthly Return |
| 23 May 2013 |
Transaction in Own Shares |
| 21 May 2013 |
Transaction in Own shares |
| 17 May 2013 |
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting |
| 16 May 2013 |
Transaction in Own shares |
| 09 May 2013 |
Shire Wins Patent Trial Against Watson concerning LIALDA® |
| 09 May 2013 |
Transaction in Own Shares |
| 08 May 2013 |
Purchase of Shares by Employee Benefit Trust |
| 08 May 2013 |
Transaction in Own Shares |
| 07 May 2013 |
Transaction in Own Shares |
| 03 May 2013 |
Director’s Share Dealings |
| 03 May 2013 |
Transaction in Own Shares |
| 02 May 2013 |
New Chief Executive reports Q1 results and sets out strategy for growth |
| 02 May 2013 |
Transaction in Own Shares |
| 01 May 2013 |
Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD |
| 01 May 2013 |
Total Voting Rights |
| 30 Apr 2013 |
Results of the 2013 Annual General Meeting (40KB PDF) |
| 30 Apr 2013 |
Transaction in Own Shares |
| 29 Apr 2013 |
Director Declaration |
| 26 Apr 2013 |
Transaction in Own Shares |
| 25 Apr 2013 |
Shire Settles All Pending Litigation with Actavis and Watson concerning INTUNIV® |
| 25 Apr 2013 |
Transaction in Own Shares |
| 24 Apr 2013 |
BRAVE Awards Now Accepting Nominations |
| 24 Apr 2013 |
Transaction in Own Shares |
| 23 Apr 2013 |
New Expert White Paper recommends framework for action to tackle impact of ADHD on individuals, families and society |
| 23 Apr 2013 |
Transaction in Own Shares |
| 22 Apr 2013 |
Shire Regenerative Medicine Joins the American Diabetes Association by Sponsoring the 2013 San Diego Tour de Cure® Cycling Event |
| 19 Apr 2013 |
Transaction in Own Shares |
| 18 Apr 2013 |
First quarter 2013 results date notification – May 2, 2013 |
| 18 Apr 2013 |
Block Listing Application |
| 18 Apr 2013 |
Transaction in Own Shares |
| 16 Apr 2013 |
Transaction in Own Shares |
| 12 Apr 2013 |
Transaction in Own Shares |
| 11 Apr 2013 |
Transaction in Own Shares |
| 10 Apr 2013 |
Transaction in Own Shares |
| 09 Apr 2013 |
Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases |
| 09 Apr 2013 |
Transaction in Own Shares |
| 05 Apr 2013 |
Transaction in Own Shares |
| 04 Apr 2013 |
Shire Regenerative Medicine Initiates Two Phase 2 Studies Evaluating SRM003 (VASCUGEL®) in Patients with End-Stage Renal Disease Undergoing Arteriovenous Access Creation for Hemodialysis |
| 03 Apr 2013 |
Transaction in own shares |
| 02 Apr 2013 |
Director/PDMR Share Dealings |
| 02 Apr 2013 |
Total Voting Rights |
| 02 Apr 2013 |
Director/PDMR Shareholding |
| 28 Mar 2013 |
2012 Annual Report – DTR 6.3.5 Disclosure |
| 28 Mar 2013 |
Transaction in Own Shares |
| 27 Mar 2013 |
Transaction in Own Shares |
| 26 Mar 2013 |
Transaction in Own Shares |
| 25 Mar 2013 |
DERMAGRAFT® now available in Canada for the treatment of Diabetic Foot Ulcers |
| 25 Mar 2013 |
Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology |
| 25 Mar 2013 |
Transaction in Own Shares |
| 22 Mar 2013 |
Transaction in Own Shares |
| 20 Mar 2013 |
Director Declaration |
| 20 Mar 2013 |
Transaction in Own Shares |
| 19 Mar 2013 |
Transaction in Own Shares |
| 15 Mar 2013 |
Transaction in Own Shares |
| 13 Mar 2013 |
Transaction in Own Shares |
| 12 Mar 2013 |
Shire Acquires Premacure AB |
| 12 Mar 2013 |
Transaction in Own Shares |
| 07 Mar 2013 |
Transaction in Own Shares |
| 06 Mar 2013 |
Transaction in Own Shares |
| 05 Mar 2013 |
Block Listing Application |
| 04 Mar 2013 |
PDMR Share Dealings |
| 01 Mar 2013 |
PDMR Share Dealings |
| 01 Mar 2013 |
Elections for Interim Dividend in Respect of the Six Months to December 31, 2012 |
| 01 Mar 2013 |
Total Voting Rights |
| 01 Mar 2013 |
Transaction in Own Shares |
| 28 Feb 2013 |
Shire Supports Rare Disease Day 2013 |
| 28 Feb 2013 |
Transaction in Own Shares |
| 26 Feb 2013 |
Transaction in Own Shares |
| 22 Feb 2013 |
Transaction in Own Shares |
| 20 Feb 2013 |
Transaction in Own Shares |
| 19 Feb 2013 |
Shire’s VPRIV® Wins First Ever “Novel Treatment Award” from Lysosomal Disease Network at their 9th WORLD Symposium |
| 18 Feb 2013 |
Transaction in Own Shares |
| 15 Feb 2013 |
Transaction in Own Shares |
| 14 Feb 2013 |
Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013 |
| 13 Feb 2013 |
Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications |
| 13 Feb 2013 |
Transaction in Own Shares |
| 12 Feb 2013 |
Elvanse® (lisdexamfetamine dimesylate) Receives UK Marketing Authorisation, Providing a New Option for the Treatment of ADHD in Children and Adolescents in the UK |
| 11 Feb 2013 |
Transaction in Own Shares |
| 08 Feb 2013 |
Shire and Impax Settle Litigation Concerning Supply of Adderall XR Authorized Generic |
| 08 Feb 2013 |
Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa |
| 07 Feb 2013 |
Transaction in Own Shares |
| 05 Feb 2013 |
Transaction in Own Shares |
| 01 Feb 2013 |
Shire reaches agreement in principle with U.S. Government |
| 01 Feb 2013 |
Full Year 2012 results date notification – February 14, 2013 |
| 01 Feb 2013 |
Total Voting Rights |
| 01 Feb 2013 |
Transaction in Own Shares |
| 31 Jan 2013 |
Transaction in Own Shares - Correction |
| 31 Jan 2013 |
Transaction in Own Shares |
| 29 Jan 2013 |
Transaction in Own Shares |
| 25 Jan 2013 |
Transaction in own shares |
| 23 Jan 2013 |
Transaction in own shares |
| 21 Jan 2013 |
Transaction in Own Shares |
| 17 Jan 2013 |
Transaction in Own Shares |
| 16 Jan 2013 |
Transaction in Own Shares |
| 15 Jan 2013 |
Shire Launches Educational Resources for Individuals with ADHD, Their Families, and Health Care Professionals |
| 14 Jan 2013 |
Transaction in Own Shares |
| 10 Jan 2013 |
Transaction in Own Shares |
| 09 Jan 2013 |
Transaction in Own Shares |
| 08 Jan 2013 |
Guidance Update |
| 08 Jan 2013 |
Shire Acquires Lotus Tissue Repair, Inc. |
| 07 Jan 2013 |
Transaction in Own Shares |
| 04 Jan 2013 |
Transaction in Own Shares |
| 03 Jan 2013 |
Transaction in Own Shares |
| 02 Jan 2013 |
Total Voting Rights |
